| Serial Number | 79346405 |
| Word Mark | BARRIOLIDES |
| Filing Date | Thursday, June 9, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 3, 2023 |
| Registration Number | 7178487 |
| Registration Date | Tuesday, October 3, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 18, 2023 |
| Goods and Services | Pharmaceutical and veterinary preparations to improve function of membranes in the body; pharmaceutical and veterinary preparations to improve function of membranes in the lung; pharmaceutical and veterinary preparations to enhance the epithelial barrier; pharmaceutical and veterinary preparations to enhance the airway epithelial barrier; pharmaceutical and veterinary preparations to inhibit inflammation; pharmaceutical and veterinary preparations for the treatment of a disease or condition that is caused by a defect in epithelial cells or tissue; pharmaceutical and veterinary preparations for the treatment of a disease or condition that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of a disease or condition of epithelial tissue in the respiratory tract; pharmaceutical and veterinary preparations for the treatment of epithelial dysfunction; pharmaceutical and veterinary preparations for the treatment of human airway epithelial cells; pharmaceutical and veterinary preparations for the treatment of chronic respiratory diseases; pharmaceutical and veterinary preparations for the treatment of viral airways diseases; pharmaceutical and veterinary preparations for the treatment of an airways disease; pharmaceutical and veterinary preparations for the treatment of asthma; pharmaceutical and veterinary preparations for the treatment of chronic obstructive pulmonary disease (COPD); pharmaceutical and veterinary preparations for the treatment of cystic fibrosis; pharmaceutical and veterinary preparations for the treatment of non-cystic fibrosis bronchiectasis; pharmaceutical and veterinary preparations for the treatment of chronic rhinosinusitis; pharmaceutical and veterinary preparations for the treatment of diffuse panbronchiolitis (DPB); pharmaceutical and veterinary preparations for the treatment of chronic bronchitis; pharmaceutical and veterinary preparations for the treatment of bronchiolitis obliterans organizing pneumonia (BOOP); pharmaceutical and veterinary preparations for the treatment of infantile respiratory distress syndrome (IRDS); pharmaceutical and veterinary preparations for the treatment of bronchopulmonary dysplasia; pharmaceutical and veterinary preparations for the treatment of neuromuscular respiratory depression or failure; pharmaceutical and veterinary preparations for the treatment of pneumonia; pharmaceutical and veterinary preparations for the treatment of conditions caused by and associated with respiratory syncytial virus (RSV) and related viruses; pharmaceutical and veterinary preparations for the treatment of a disease or condition commonly associated with inflammation that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of systemic inflammatory distress syndrome (SIRS); pharmaceutical and veterinary preparations for the treatment of adult respiratory distress syndrome (ARDS); pharmaceutical and veterinary preparations for the treatment of inflammatory bowel disease; pharmaceutical and veterinary preparations for the treatment of ulcerative colitis; pharmaceutical and veterinary preparations for the treatment of Crohn's disease; sanitary preparations for medical purposes; dietary supplements for human beings and animals |
| Goods and Services | Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; biological preparations for use in industry and science |
| Goods and Services | Scientific and technological services and research and design relating thereto, namely, scientific research in the field of pharmaceutical studies research, scientific research in new pharmaceutical design services, medical and pharmacological research services, drug discovery services, pharmaceutical drug development services, pharmaceutical research and development; industrial analysis and research services, namely, pharmaceutical analysis and pharmaceutical research |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 4, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 4, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EpiEndo Pharmaceuticals ehf. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 78 - NOT AVAILABLE |
| Address | IS |
| Party Name | EpiEndo Pharmaceuticals ehf. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 78 - NOT AVAILABLE |
| Address | IS |
| Party Name | EpiEndo Pharmaceuticals ehf. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 78 - NOT AVAILABLE |
| Address | IS |
| Event Date | Event Description |
| Tuesday, January 30, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, January 8, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, January 8, 2024 | FINAL DISPOSITION PROCESSED |
| Wednesday, January 3, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, October 3, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, October 3, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 18, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 18, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 28, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sunday, June 18, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, June 15, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 14, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, June 14, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, June 14, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, June 14, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, June 14, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, May 22, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, May 22, 2023 | REFUSAL PROCESSED BY MPU |
| Friday, March 31, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, March 30, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, March 24, 2023 | ASSIGNED TO EXAMINER |
| Sunday, November 20, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, August 9, 2022 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 3, 2022 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, July 28, 2022 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |